Clinical trial of MBX 1416 for Post-Bariatric Hypoglycemia beginsThe first participant has been dosed in MBX Biosciences’ Phase 1/2 clinical trial of MBX 1416, the company’s long-acting glucagon-like...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment2 days ago